February 10, 2021
“By the end of March, we’re likely going to have more than 200 million doses of the vaccines available,” explains Raymond James Healthcare Policy Analyst Chris Meekins.
Recorded February 1, 2021
Markets & Investing March 31, 2023 Review the latest Weekly Headings by CIO Larry Adam. Key...
Markets & Investing March 31, 2023 Review the latest portfolio strategy commentary from Mike Gibbs,...
Economy & Policy March 31, 2023 Chief Economist Eugenio J. Alemán discusses current economic...